Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb;36(2):350-351.
doi: 10.1038/s41433-021-01531-z.

Infographic: Effect of face-down positioning vs support-the-break positioning after macula-involving retinal detachment repair: the PostRD randomised clinical trial

Affiliations
Randomized Controlled Trial

Infographic: Effect of face-down positioning vs support-the-break positioning after macula-involving retinal detachment repair: the PostRD randomised clinical trial

Salman Naveed Sadiq et al. Eye (Lond). 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1
Fig. 1
This PostRD trial involving patients with macula involving rhegmatogenous retinal detachment showed that face-down positioning led to a reduction in the rate and amplitude of postoperative retinal displacement and binocular diplopia in comparison with support-the-break positioning. However, no differences were found in best-corrected visual acuity, distortion and quality of life scores between the groups. RRD rhegmatogenous retinal detachment, LA local anesthesia, ITT intention-to-treat, ERM epiretinal membrane, BCVA best-corrected visual acuity, FAF fundus autofluorescence imaging, QoL quality of life, IOP intraocular pressure.

References

    1. Casswell EJ, Yorston D, Lee E, Heeren TF, Harris N, Zvobgo TM, et al. Effect of face-down positioning vs support-the-break positioning after macula-involving retinal detachment repair: the PostRD randomized clinical trial. JAMA Ophthalmol. 2020;138:634–42. doi: 10.1001/jamaophthalmol.2020.0997. - DOI - PMC - PubMed

Publication types